MarkNtel Advisors recently published a detailed industry analysis of the Global Colorectal Cancer (CRC) Diagnostics and Treatments Market. The report covers growth trends, geographical marketing strategies, challenges, opportunities, and drivers influencing the market.
Global Colorectal Cancer (CRC) Diagnostics and Treatments Market, Share, and Trends Analysis Report – Industry Overview and Forecast to 2030
The Colorectal Cancer (CRC) Diagnostics and Treatments Market size was valued at around USD10.89 Billion in 2024 and is projected to reach USD16.89 Billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 7.6% during the forecast period, i.e., 2025-30.
Key Findings in Global Colorectal Cancer (CRC) Diagnostics and Treatments Market:
- Historical Analysis: 2020–2023
- Base Year: 2024
- Forecast Period: 2025–2030
Leading Market Players- Abbott Laboratories, Amgen Inc., Bayer AG, Bristol Myers Squibb, Eli Lilly and Company, GlaxoSmithKline PLC, F. Hoffmann-La Roche AG, Merck & Co., Inc., Novartis International AG, Pfizer Inc
Key Highlights of the Report
- Market Dimensions & Projections
- Pricing Evaluation,
- Recent Strategic Moves by Companies,
- Primary Stakeholders,
- Analysis of Import and Export Trends,
- Competitive Landscape Assessment,
- Emerging Opportunities,
- Market Trends and Indicators
What are the major Driver the Global Colorectal Cancer (CRC) Diagnostics and Treatments industry?
High Ubiquity of Colorectal Cancer Driving Demand – Globally, colorectal cancer is a major health concern. 930,000 people died and 10. 9 million new cases were reported worldwide in 2020. The number of cases is expected to increase to 32. 2 million by 2040, with 12. 6 million expected deaths. The disease is most common in countries with high or extremely high HDI. With 10% of cases worldwide, it is the second most common cause of cancer-related deaths and the third most common type of cancer overall. Different geographic prevalence rates indicate that colorectal cancer (CRC) is most common in Australia, New Zealand, and Europe, while it is less common in some parts of Africa and Southern Asia.
These geographic disparities underscore the necessity for regional strategies in CRC management. In light of the increasing incidence of CRC, novel diagnostic technologies are being created. A recent innovation involves a small robot that can travel through the digestive tract and conduct 3D scans to facilitate improved early detection and treatment. The high incidence will drive the market growth throughout the forecast period and beyond.
Download now and gain valuable insights to inform your business strategy, drive growth, and stay ahead of the competition – Download Free PDF Sample– https://www.marknteladvisors.com/query/request-sample/colorectal-cancer-crc-market.html
What segments define the Global Colorectal Cancer (CRC) Diagnostics and Treatments Market from 2025 to 2030? How do these segments contribute to market dynamics and growth?
By Diagnosis
- Blood & Stool Tests
- Imaging
- Biopsy
- Flexible Sigmoidoscopy
- Colonoscopy
By Treatment
- Chemotherapy
- Alkylating Agents
- Antimetabolites
- Fluorouracil
- Capecitabine
- Others
- Immunotherapy
- Monoclonal Antibodies
- Bevacizumab
- Cetuximab
- Panitumumab
- Biologic Response Modifiers
- Colony-Stimulating Factors
- Tumor Vaccines
- Monoclonal Antibodies
- Surgery
- Targeted Therapy
- Others (Radiofrequency Ablation (RFA), etc.)
According to report, Based on the treatment, Chemotherapy leads the Global Colorectal Cancer (CRC) Diagnostics and Treatments Market. It holds approx. 50% share of the total market.
By End-User
- Hospitals
- Specialty Clinics
- Others (Ambulatory Surgery Centers, etc.)
According to report, Based on end-users, hospitals dominate the Global Colorectal Cancer (CRC) Diagnostics and Treatments Market. It holds approx. 42% of the total market.
Explore the Complete Global Colorectal Cancer (CRC) Diagnostics and Treatments Market Analysis Report – https://www.marknteladvisors.com/research-library/colorectal-cancer-crc-market.html
Geographical Analysis: Global Colorectal Cancer (CRC) Diagnostics and Treatments Market
By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
The Global Colorectal Cancer (CRC) Diagnostics and Treatments Industry Recent Development:
- January 2025: Amgen Inc. got approval from the FDA to expand the label of its KRAS inhibitor Lumakras (sotorasib), opening up its use in colorectal cancer. With this, Lumakras can now be combined with another Amgen asset, the antibody Vectibix (panitumumab), to treat adult patients with metastatic disease who are carrying the G12C KRAS mutation.
Key Questions Addressed in This Study
- What are the primary factors driving the growth of the Global Colorectal Cancer (CRC) Diagnostics and Treatments Market?
- How is the Global Colorectal Cancer (CRC) Diagnostics and Treatments Market expected to evolve over the next five years?
- What key insights can be drawn from current trends shaping the market?
- What is the current market size, and how is it forecasted to change in the coming years?
- What is the future outlook for the market in terms of technological innovation and geographic expansion?
For a Customized Analysis Report, Just Drop Your Inquiry Here – https://www.marknteladvisors.com/query/request-customization/colorectal-cancer-crc-market.html
Why MarkNtel Advisors?
MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
More Research Studies Report:
–Biocomposites Market size was valued at around USD 36.9 billion in 2025 and is projected to reach USD 89 billion by 2030 with a CAGR of around 119.27%.
–Green Solvents Market size was valued at around USD 1.34 billion in 2025 & is projected to reach USD 1.87 billion by 2030 with a CAGR of around 5.7%.
For Media Inquiries, Please Contact:
Email: sales@marknteladvisors.com
Trending Blogs : www.marknteladvisors.com/blogs
Export-import Data : https://www.marknteladvisors.com/export-import-data
